SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.788
AS - Asia 11.437
EU - Europa 7.508
SA - Sud America 1.864
AF - Africa 177
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 49.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.348
SG - Singapore 4.673
CN - Cina 3.386
DE - Germania 1.762
BR - Brasile 1.568
UA - Ucraina 1.449
IT - Italia 1.104
HK - Hong Kong 1.096
TR - Turchia 912
GB - Regno Unito 889
FI - Finlandia 704
VN - Vietnam 642
RU - Federazione Russa 390
SE - Svezia 365
CA - Canada 213
PL - Polonia 196
MX - Messico 184
FR - Francia 172
ID - Indonesia 143
IN - India 143
AR - Argentina 112
JP - Giappone 106
NL - Olanda 91
BE - Belgio 86
ZA - Sudafrica 82
BD - Bangladesh 80
ES - Italia 62
EC - Ecuador 55
LT - Lituania 50
IE - Irlanda 48
IQ - Iraq 46
CZ - Repubblica Ceca 36
AT - Austria 32
CL - Cile 27
PY - Paraguay 27
PK - Pakistan 24
CO - Colombia 22
MA - Marocco 22
SA - Arabia Saudita 22
AE - Emirati Arabi Uniti 20
UZ - Uzbekistan 20
IR - Iran 19
VE - Venezuela 17
KE - Kenya 15
NP - Nepal 14
UY - Uruguay 14
KR - Corea 13
PE - Perù 13
TN - Tunisia 13
DZ - Algeria 12
EG - Egitto 12
AZ - Azerbaigian 11
IL - Israele 11
AU - Australia 10
CH - Svizzera 9
RO - Romania 9
DO - Repubblica Dominicana 8
JO - Giordania 8
NZ - Nuova Zelanda 8
BG - Bulgaria 7
SN - Senegal 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AL - Albania 6
GR - Grecia 6
LB - Libano 6
PA - Panama 6
DK - Danimarca 5
EU - Europa 5
GY - Guiana 5
MY - Malesia 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BH - Bahrain 4
BO - Bolivia 4
HN - Honduras 4
JM - Giamaica 4
LU - Lussemburgo 4
LV - Lettonia 4
NI - Nicaragua 4
RS - Serbia 4
SV - El Salvador 4
CY - Cipro 3
ET - Etiopia 3
HR - Croazia 3
KW - Kuwait 3
KZ - Kazakistan 3
NG - Nigeria 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
GE - Georgia 2
GT - Guatemala 2
KH - Cambogia 2
MD - Moldavia 2
OM - Oman 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
YE - Yemen 2
Totale 49.783
Salva come PNG Salva come JPEG
Città #
Fairfield 3.307
Woodbridge 2.890
Ashburn 2.752
Singapore 2.632
Houston 1.980
Jacksonville 1.594
Ann Arbor 1.518
Chandler 1.392
Seattle 1.356
Wilmington 1.182
Cambridge 1.156
Beijing 1.114
Santa Clara 1.113
Dallas 1.100
Hong Kong 1.083
Munich 615
Izmir 546
Nanjing 457
Los Angeles 400
New York 360
Princeton 355
Ferrara 324
San Diego 281
Boardman 263
Helsinki 259
Milan 221
Ho Chi Minh City 216
Shanghai 205
São Paulo 174
Warsaw 174
Nanchang 138
Shenyang 129
Turku 128
Dearborn 127
London 121
Hanoi 120
Mexico City 113
Falkenstein 109
Hefei 102
Tianjin 96
Tokyo 96
Jakarta 95
Falls Church 92
Brussels 82
Brooklyn 81
Hebei 81
San Mateo 81
Norwalk 78
Moscow 77
Jiaxing 75
Bremen 74
Frankfurt am Main 71
Changsha 68
Chicago 68
Buffalo 66
Redwood City 64
Mountain View 63
Montreal 62
The Dalles 60
Atlanta 58
Jinan 58
Johannesburg 54
Rio de Janeiro 54
Denver 52
San Francisco 52
Toronto 52
Orem 50
Addison 48
Auburn Hills 48
Dublin 47
Washington 46
Dong Ket 45
Chennai 44
Kunming 44
Stockholm 44
Zhengzhou 44
Bologna 43
Boston 42
Guangzhou 42
Philadelphia 41
Phoenix 39
Poplar 37
Belo Horizonte 35
Manchester 35
Ankara 30
Mcallen 30
Columbus 29
Montréal 29
Mumbai 29
Padova 28
Tappahannock 28
Des Moines 27
Ningbo 27
Orange 27
Amsterdam 26
Indiana 26
Brasília 25
Biên Hòa 23
Dhaka 23
Curitiba 22
Totale 35.219
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 952
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 341
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 332
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 313
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 285
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 274
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 254
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 246
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 238
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 233
A new selective antagonist of the nociceptin receptor 232
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 220
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 217
A new ligand for the urotensin II receptor 216
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 214
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 212
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 209
null 205
Actual concept of "probiotics": is it more functional to science or business? 204
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 204
The effect of guanethidine and local anaesthetics on the electrically stimulated mouse vas deferens 203
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 203
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 203
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 201
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 201
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 201
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 201
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 200
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 199
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 197
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 197
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 197
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 196
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 195
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 193
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 192
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 192
Modulation of the NOP receptor signaling affects resilience to acute stress 192
Effects of vasoactive agents in healthy and diseased human saphenous veins 191
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 190
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 190
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 190
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 189
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 188
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 188
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 188
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 188
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 185
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 185
Pharmacological characterization of tachykinin tetrabranched derivatives 185
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 184
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 184
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 184
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 184
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 183
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 183
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 182
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 181
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 181
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 180
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 179
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 179
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 179
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 178
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 177
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 176
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 176
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 176
Pharmacological characterization of nociceptin receptor: an in vitro study 176
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 175
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 175
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 173
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 172
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 172
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 172
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 172
Sudden death from pulmonary thromboembolism: chronobiological aspects 171
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 171
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 171
A simple method for electrical field stimulation of cultured granule cells 171
Pharmacological characterisation of novel kinin B2 receptor ligands 170
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 170
B1 and B2 kinin receptors in various species 169
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 169
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation 168
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 168
Neuropeptide S receptor ligands: a patent review (2005-2016) 168
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 168
Abdominal pain and diarrhoea caused by topical clindamycin phosphate 167
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 167
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 166
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 166
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 165
Structure-activity study at positions 3 and 4 of human neuropeptide S. 164
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 164
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 164
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 163
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 163
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 163
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 162
Totale 20.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 238.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.282
Totale 242.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.866 0 0 0 0 0 489 167 567 154 634 577 278
2021/20223.644 144 369 312 217 203 190 217 236 156 302 313 985
2022/20233.455 379 160 114 414 572 485 177 315 470 21 196 152
2023/20241.783 196 229 88 50 99 310 74 142 35 30 53 477
2024/20257.710 184 203 632 256 875 769 271 496 1.226 795 1.075 928
2025/202611.875 2.223 1.107 2.409 2.779 3.039 318 0 0 0 0 0 0
Totale 50.306